Tokyo, Sept. 20 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059135) titled 'Study on Initial Management of Epistaxis in the Emergency Department' on Sept. 19.
Study Type:
Interventional
Study Design:
Basic Design - Parallel
Randomization - Randomized
Blinding - Open -no one is blinded
Control - Active
Primary Sponsor:
Institute - Aizawa Hospital, Department of Otolaryngology
Condition:
Condition - Epistaxis (Nosebleed)
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - This study was intended to show the differences in hemostasis between resolvable and non-resolvable packing materials, compare patients' demographics, and assess physicians' mental workloads during the treatment of epistaxis.
Basic objectives2 - Safety,Efficacy
Intervention:
Interventions/Control_1 - Resorbable hemostatic material nasal packing
Interventions/Control_2 - Non-resorbable gauze nasal packing
Eligibility:
Age-lower limit - 18
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Adults (above 18 years) presenting to the emergency department who required treatment for epistaxis.
Key exclusion criteria - Epistaxis due to multiple trauma or a consciousness disorder.Known hemorrhagic (bleeding) disorders.
Target Size - 100
Recruitment Status:
Recruitment status - No longer recruiting
Date of protocol fixation - 2020 Year 11 Month 01 Day
Date of IRB - 2020 Year 12 Month 24 Day
Anticipated trial start date - 2021 Year 06 Month 01 Day
Last follow-up date - 2024 Year 12 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067638
Disclaimer: Curated by HT Syndication.
